Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 24.47M | $150.0M | 11.91% | -- | 2026-06-30 |
| Bain Capital Life Sciences Investors, LLC | 17.60M | $108.0M | 8.57% | -- | 2026-06-30 |
| Venrock Adviser, LLC | 14.75M | $90.0M | 7.18% | +1.01M | 2026-06-30 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 13.57M | $83.0M | 6.61% | -- | 2026-06-30 |
| BlackRock, Inc. | 12.49M | $76.0M | 6.08% | +1.20M | 2026-06-30 |
| TCG Crossover Management, LLC | 12.36M | $76.0M | 6.02% | -- | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 9.72M | $59.0M | 4.73% | -- | 2026-06-30 |
| Polar Capital Holdings Plc | 9.54M | $58.0M | 4.65% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.93M | $48.0M | 3.86% | +148.6K | 2026-06-30 |
| Nantahala Capital Management, LLC | 6.98M | $42.0M | 3.40% | -368.0K | 2026-06-30 |
